Satoris
closedSatoris develops tests for neurological diseases such as Alzheimer’s, Parkinson’s, Multiple Sclerosis, and Diabetic Neuropathy.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD28—43m (Dealroom.co estimates Mar 2008.)
Redwood City California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.2m | Series B | ||
| Total Funding | CAD7.1m | ||